They exist to develop curative solutions that achieve total and faster healing for non-healing wounds and other complex inflammatory diseases with their four-in-one biologic drug, AUP-16. Their goal is to create solid Phase 2 clinical efficacy data in diabetic foot ulcers and non-clinical proof-of-concept data in other inflammatory diseases by end of 2022, and to engage with strategic partners to ensure that this game changing technology benefits millions of patients.

Rocsole builds the world’s leading industrial imaging solutions—turning real-time insights into actionable intelligence for unmatched efficiency, reliability, and ROI. Our award-winning technology combines advanced tomographic imaging, AI-powered prediction software, and proven performance in the harshest environments—delivering data no other solution can provide. We transform industrial imaging into measurable ROI and scalable impact. To meet surging global demand, we are raising a Series B round. Team: Rocsole’s team combines deep scientific expertise with real-world industrial execution. Born from cutting-edge research in tomography and imaging, we’ve deployed advanced technologies where few others could. Our leadership brings decades of experience in oil & gas, energy, and process industries—giving us a sharp understanding of customer pain points and how to solve them. Today, we’re a 20+ person team representing 7 nationalities, powered by 4 PhDs driving innovation in imaging and AI. With multiple patents granted and a proven track record with global industry leaders, our AI specialists deliver predictive modelling and industrial analytics that scale. We don’t just build tech—we build trust, scalability, and measurable impact. Product: Rocsole delivers award-winning industrial imaging powered by advanced sensors and AI-driven software—giving operators real-time visibility into processes others can’t see. Our proprietary electrical tomography technology is installed directly on critical process assets to detect deposits, emulsions, and flow regimes that are otherwise invisible. The AI layer transforms raw data into predictive insights operators can act on instantly. This globally unique solution functions as a digital window into harsh industrial environments—enabling smarter decisions, reduced downtime, and measurable ROI. Market: Rocsole targets industries where efficiency, reliability, and safety are mission-critical. With 30+ active customers—including global leaders like ExxonMobil, Aramco, Petrobras, and Halliburton—our technology is proven across geographies and harsh environments. While energy is our core market, the same challenges exist in chemicals, pulp & paper, mining, water treatment, and semiconductors—unlocking massive cross-sector growth potential. Designed for large-scale industrial players, our solutions cut downtime, reduce costs, and improve sustainability. Rocsole is positioned to capture a significant share of this multi-billion-dollar global market. Competition: Most players rely on traditional level indicators and basic sensors—offering indirect or delayed measurements that fall short for industries driven by digitalisation. Rocsole stands apart with globally unique real-time imaging inside harsh industrial processes, powered by electrical tomography and advanced AI analytics. We don’t just measure—we see, predict, and empower operators to act, improving efficiency, safety, and sustainability.

Adamant Health’s unique technology to analyse Parkinson’s disease symptoms is based on over 15 years of academic research at the University of Eastern Finland. With the technology, clinicians have several days detailed visibility to the patient’s symptoms and is able to optimise the treatment accordingly. Pharma companies benefit from the objective and long-term RW data in their clinical and post market studies and can utilise it as complementary diagnostics tool for personalised medication.

WellO2 offers a convenient and natural help to people having breathing problems due to acute or chronic respiratory diseases. WellO2 creates a new respiratory therapy by leveraging the effects of two well known methods of treating airways. First resisted exhaling into the device opens up the airways and strengthens the breathing organs. Then warm vapour inhaling brings moisture deep into the airways soothing the mucous membranes and helping to loose and detach irritating mucus.

3D Talo specializes in leveraging virtual and augmented reality for rehabilitation, providing top-notch software and services. They also offer laser scanning, photogrammetry, and 360-degree environment documentation.

Keltamusta Media is a media company that offers streaming and content production services for businesses, associations, and individuals across Finland. The company provides a dedicated streaming platform, strm.fi, for paid or private broadcasts. Free live broadcasts are typically directed to online services like YouTube, while other social media platforms such as Facebook and Instagram are also utilized. Keltamusta Media produces media content tailored to specific purposes, including advertising and social media.

Tracemation specializes in providing traceability and automation solutions aimed at enhancing value chain efficiencies for the manufacturing industry. The company focuses on delivering systems that enable businesses to track and manage their production processes more effectively. By integrating traceability into manufacturing operations, Tracemation aims to help clients improve operational visibility, ensure product quality, and optimize production workflows. The solutions offered are designed to be user-friendly, catering to the specific needs of manufacturers looking to streamline their processes and enhance productivity.

Refine Reality is a virtual reality-driven game studio that develops interactive games.

Luowa specializes in software development and digital media creation, prioritizing seamless integration of website design with content at the forefront. By focusing on designing websites around content, they ensure a user-centered approach that maximizes engagement and functionality.

They have been developing e-commerce platforms for 3D Printed items since 2013. Their solution offers you full controll to your IP with freedom of choosing your 3D Printing partner. Their taylor made solutions are perfect as well to games as to industrial spare parts and services.They are experts in 3D Printing, Digital Media and Strategic Processes with attidue of 110 % Entrepreneurship.

They exist to develop curative solutions that achieve total and faster healing for non-healing wounds and other complex inflammatory diseases with their four-in-one biologic drug, AUP-16. Their goal is to create solid Phase 2 clinical efficacy data in diabetic foot ulcers and non-clinical proof-of-concept data in other inflammatory diseases by end of 2022, and to engage with strategic partners to ensure that this game changing technology benefits millions of patients.

Rocsole builds the world’s leading industrial imaging solutions—turning real-time insights into actionable intelligence for unmatched efficiency, reliability, and ROI. Our award-winning technology combines advanced tomographic imaging, AI-powered prediction software, and proven performance in the harshest environments—delivering data no other solution can provide. We transform industrial imaging into measurable ROI and scalable impact. To meet surging global demand, we are raising a Series B round. Team: Rocsole’s team combines deep scientific expertise with real-world industrial execution. Born from cutting-edge research in tomography and imaging, we’ve deployed advanced technologies where few others could. Our leadership brings decades of experience in oil & gas, energy, and process industries—giving us a sharp understanding of customer pain points and how to solve them. Today, we’re a 20+ person team representing 7 nationalities, powered by 4 PhDs driving innovation in imaging and AI. With multiple patents granted and a proven track record with global industry leaders, our AI specialists deliver predictive modelling and industrial analytics that scale. We don’t just build tech—we build trust, scalability, and measurable impact. Product: Rocsole delivers award-winning industrial imaging powered by advanced sensors and AI-driven software—giving operators real-time visibility into processes others can’t see. Our proprietary electrical tomography technology is installed directly on critical process assets to detect deposits, emulsions, and flow regimes that are otherwise invisible. The AI layer transforms raw data into predictive insights operators can act on instantly. This globally unique solution functions as a digital window into harsh industrial environments—enabling smarter decisions, reduced downtime, and measurable ROI. Market: Rocsole targets industries where efficiency, reliability, and safety are mission-critical. With 30+ active customers—including global leaders like ExxonMobil, Aramco, Petrobras, and Halliburton—our technology is proven across geographies and harsh environments. While energy is our core market, the same challenges exist in chemicals, pulp & paper, mining, water treatment, and semiconductors—unlocking massive cross-sector growth potential. Designed for large-scale industrial players, our solutions cut downtime, reduce costs, and improve sustainability. Rocsole is positioned to capture a significant share of this multi-billion-dollar global market. Competition: Most players rely on traditional level indicators and basic sensors—offering indirect or delayed measurements that fall short for industries driven by digitalisation. Rocsole stands apart with globally unique real-time imaging inside harsh industrial processes, powered by electrical tomography and advanced AI analytics. We don’t just measure—we see, predict, and empower operators to act, improving efficiency, safety, and sustainability.

Adamant Health’s unique technology to analyse Parkinson’s disease symptoms is based on over 15 years of academic research at the University of Eastern Finland. With the technology, clinicians have several days detailed visibility to the patient’s symptoms and is able to optimise the treatment accordingly. Pharma companies benefit from the objective and long-term RW data in their clinical and post market studies and can utilise it as complementary diagnostics tool for personalised medication.

NEWICON OY is a fast-growing health technology company founded in 2007 and it is the market leader in pharmacy automation systems in Finland. The company has delivered pharmacy automation solutions to more than 100 pharmacies and hospitals in Finland, Denmark, Russia, Israel, Iran and China. Currently, NewIcon Oy has about 70 employees and a turnover of over € 7 million. The company uses the certified ISO 9001 quality management system.

They exist to develop curative solutions that achieve total and faster healing for non-healing wounds and other complex inflammatory diseases with their four-in-one biologic drug, AUP-16. Their goal is to create solid Phase 2 clinical efficacy data in diabetic foot ulcers and non-clinical proof-of-concept data in other inflammatory diseases by end of 2022, and to engage with strategic partners to ensure that this game changing technology benefits millions of patients.

Rocsole builds the world’s leading industrial imaging solutions—turning real-time insights into actionable intelligence for unmatched efficiency, reliability, and ROI. Our award-winning technology combines advanced tomographic imaging, AI-powered prediction software, and proven performance in the harshest environments—delivering data no other solution can provide. We transform industrial imaging into measurable ROI and scalable impact. To meet surging global demand, we are raising a Series B round. Team: Rocsole’s team combines deep scientific expertise with real-world industrial execution. Born from cutting-edge research in tomography and imaging, we’ve deployed advanced technologies where few others could. Our leadership brings decades of experience in oil & gas, energy, and process industries—giving us a sharp understanding of customer pain points and how to solve them. Today, we’re a 20+ person team representing 7 nationalities, powered by 4 PhDs driving innovation in imaging and AI. With multiple patents granted and a proven track record with global industry leaders, our AI specialists deliver predictive modelling and industrial analytics that scale. We don’t just build tech—we build trust, scalability, and measurable impact. Product: Rocsole delivers award-winning industrial imaging powered by advanced sensors and AI-driven software—giving operators real-time visibility into processes others can’t see. Our proprietary electrical tomography technology is installed directly on critical process assets to detect deposits, emulsions, and flow regimes that are otherwise invisible. The AI layer transforms raw data into predictive insights operators can act on instantly. This globally unique solution functions as a digital window into harsh industrial environments—enabling smarter decisions, reduced downtime, and measurable ROI. Market: Rocsole targets industries where efficiency, reliability, and safety are mission-critical. With 30+ active customers—including global leaders like ExxonMobil, Aramco, Petrobras, and Halliburton—our technology is proven across geographies and harsh environments. While energy is our core market, the same challenges exist in chemicals, pulp & paper, mining, water treatment, and semiconductors—unlocking massive cross-sector growth potential. Designed for large-scale industrial players, our solutions cut downtime, reduce costs, and improve sustainability. Rocsole is positioned to capture a significant share of this multi-billion-dollar global market. Competition: Most players rely on traditional level indicators and basic sensors—offering indirect or delayed measurements that fall short for industries driven by digitalisation. Rocsole stands apart with globally unique real-time imaging inside harsh industrial processes, powered by electrical tomography and advanced AI analytics. We don’t just measure—we see, predict, and empower operators to act, improving efficiency, safety, and sustainability.

Adamant Health’s unique technology to analyse Parkinson’s disease symptoms is based on over 15 years of academic research at the University of Eastern Finland. With the technology, clinicians have several days detailed visibility to the patient’s symptoms and is able to optimise the treatment accordingly. Pharma companies benefit from the objective and long-term RW data in their clinical and post market studies and can utilise it as complementary diagnostics tool for personalised medication.

They exist to develop curative solutions that achieve total and faster healing for non-healing wounds and other complex inflammatory diseases with their four-in-one biologic drug, AUP-16. Their goal is to create solid Phase 2 clinical efficacy data in diabetic foot ulcers and non-clinical proof-of-concept data in other inflammatory diseases by end of 2022, and to engage with strategic partners to ensure that this game changing technology benefits millions of patients.

Adamant Health’s unique technology to analyse Parkinson’s disease symptoms is based on over 15 years of academic research at the University of Eastern Finland. With the technology, clinicians have several days detailed visibility to the patient’s symptoms and is able to optimise the treatment accordingly. Pharma companies benefit from the objective and long-term RW data in their clinical and post market studies and can utilise it as complementary diagnostics tool for personalised medication.

WellO2 offers a convenient and natural help to people having breathing problems due to acute or chronic respiratory diseases. WellO2 creates a new respiratory therapy by leveraging the effects of two well known methods of treating airways. First resisted exhaling into the device opens up the airways and strengthens the breathing organs. Then warm vapour inhaling brings moisture deep into the airways soothing the mucous membranes and helping to loose and detach irritating mucus.